Loading...
  • benefits
  • Of 114,766 seniors without drug benefits, 55 percent initiated drug insurance under Part D. After the penalty-free Part D enrollment period, use of statins, clopidogrel, and proton pump inhibitors stabilized at levels ranging from 11 percent to 37 percent above the trend that would have been expected if Part D had not been implemented. (rwjf.org)
  • 2016
  • The company was turned down by the FDA in April 2016 after the agency said the drug failed to demonstrate "substantial evidence of efficacy. (thestreet.com)
  • The Centers for Medicare and Medicaid Services reports that in 2016 prices grew by a modest 2.1 percent for all drugs , and even slower growth is expected this year. (biotech-now.org)
  • A review by QuintilesIMS of drug spending revealed that the net price for branded drugs grew by just 3.5 percent in 2016, and this stability is expected to continue in the coming years. (biotech-now.org)
  • 2019
  • They also want to eliminate the drug coverage gap known as the "doughnut hole" one year earlier than currently scheduled, in 2019 instead of 2020. (ktar.com)
  • Hospitals
  • Hospitals in Canada manage their formularies - the list of generic and brand-name drugs they dispense - independently. (redorbit.com)
  • After the increase, three of the Salt Lake City-based University of Utah Health Care's hospitals were spending up to $55,000 a month on the drug, up from $20,000 to $25,000 a month. (aha.org)
  • With drug costs threatening to consume more of their budgets, hospitals are turning to experts like Klein. (latimes.com)
  • These anaesthetists demonstrated awareness of pharmacoeconomic issues, believed that cheaper anaesthetic agents could be used without compromising quality of care, identified few hospitals with policies that restricted drug use, ssand indicated drug cost education could be improved. (springer.com)
  • Control and responsibility of drug utilization were shared within their hospitals. (springer.com)
  • The AIFA will conduct comparisons of pharmaceutical expenditures in each of Italy's 20 regions, in order to ensure that the most efficient cost-containment measures are implemented relevant to each region's particular situation, and will centralise purchasing by hospitals and local health authorities. (pharmatimes.com)
  • and the rise of capitated primary care groups-which accept budgets for each patient and manage risk if costs exceed budgets-in Medicare Advantage will take a toll on hospitals by offering viable alternatives. (fortune.com)
  • policymakers
  • Umbdenstock noted the AHA's support for the Campaign for Sustainable Rx Pricing, a project of the National Coalition of Health Care designed to focus the public's and policymakers' attention on high-cost drugs. (aha.org)
  • This doesn't mean some families aren't feeling the pressure of drug costs, or that policymakers shouldn't look for opportunities to expand access to affordable medicines. (biotech-now.org)
  • chronic
  • While noting that the cost of drugs for many other cancers were just as high, the doctors focused on what they know best - the medicines for chronic myeloid leukemia, like Gleevec, which is enormously profitable for Novartis. (nytimes.com)
  • For maintenance drugs to treat chronic ailments such as asthma, PBMs are encouraging employees to use mail-order service, which reduces dispensing costs. (chicagobusiness.com)
  • She said, "Our findings are particularly troublesome given the increased reliance on prescription drugs to treat chronic conditions," adding, "People who go without their prescriptions experience worsening health and complications. (californiahealthline.org)
  • budgets
  • Being able to predict prescribing costs is very important, he adds, especially when there are so many demands and pressures on healthcare budgets. (emaxhealth.com)
  • expensive
  • Substituting the least expensive version of each drug could have saved $1.6 million, or 47 per cent, for PPIs, Dr. Bell found. (redorbit.com)
  • And those drugs are even more expensive. (nytimes.com)
  • The Supreme Court in India ruled recently that the drug could not be patented, clearing the way for use of far less expensive generic alternatives. (nytimes.com)
  • Some of the doctors who signed on to the commentary said they were inspired by physicians at the Memorial Sloan-Kettering Cancer Center in New York, who last fall refused to use a new colon cancer drug, Zaltrap, because it was twice as expensive as another drug without being better. (nytimes.com)
  • Americans took home some 2.8 billion prescriptions last year, obtaining some of the newest, most heavily advertised and most expensive drugs. (orlandosentinel.com)
  • The drug is expensive, ranging in cost from $300,000 to $1.5 million a year, according to the letter, and Sarepta's failure to mention the federal funding in the patent documents is a violation of federal law. (thestreet.com)
  • Ninety-four per cent considered cost when choosing anaesthetic agents, 63.7% indicated cheaper drugs could be used without decreasing quality of care, and 46.3% that restricted access to expensive agents was justified. (springer.com)
  • Fifty-three per cent considered resident education about drug cost to be inadequate, and 57.4% indicated that resident teaching justified the use of expensive agents. (springer.com)
  • Maine's governor, Paul LePage, signed a bill into law on Monday that would set a yearly cap on patient payments for such expensive drugs. (nytimes.com)
  • Our population is progressively ageing, we are better at detecting problems than 15 years ago and more expensive drugs are being developed. (emaxhealth.com)
  • high cost
  • They know if the patient is getting the value for the high-cost drug," said Steven Rough, director of pharmacy for the University of Wisconsin Hospital and Clinics, which began handling transplant drugs in 2006 and expanded its specialty pharmacy in 2011. (businessinsurance.com)
  • medicines
  • Although Klein does not have the final say on which medicines make it onto the hospital's list of preferred drugs, her opinion carries weight. (latimes.com)
  • But even so, the overall current cost to consumers is substantial, since Claritin and the other drugs in question are among the top-selling prescription medicines. (nytimes.com)
  • What do you do about these new medicines that are coming out that the drug company can set a price at any price they want to? (kplctv.com)
  • Accelerating the delivery of lower-cost generic medicines. (biotech-now.org)
  • In June, the FDA announced a number of steps to do just that, such as expediting the review of generic-drug applications for medicines that lack robust competition. (biotech-now.org)
  • Trump
  • The White House proposal would put Trump in the middle of a tug-of-war between drug companies on one side and insurers and pharmacy benefit managers on the other, with billions of dollars at stake. (ktar.com)
  • formulary
  • As for drug formulary lists, 71% of organizations have this tool in place, and 63% are using a pharmacy benefit manager (PBM). (ifebp.org)
  • I've seen HMOs decide not to include a certain drug on their formulary," says Allan Fine, a senior manager in the health care consulting practice at Ernst & Young LLP in Chicago. (chicagobusiness.com)
  • Coverage
  • The net cost to the federal government for the drug coverage in 2006 is expected to be $30.5 billion down from a previously estimated $38.1 billion. (cms.gov)
  • State government savings are the result of lower phased-down contributions for the drug coverage. (cms.gov)
  • An Old Debate About Adding Drug Coverage To Medicare Has A New Focus Designed To Control Costs. (orlandosentinel.com)
  • Some health plans are planning to drop almost all coverage for prescription allergy drugs. (nytimes.com)
  • The Affordable Health Care Act was supposed to control health care costs and make health coverage available to all Americans. (patheos.com)
  • Then the manufacturer of that drug runs an ad in local newspapers baiting the HMO to pick up coverage. (chicagobusiness.com)
  • But the issue gets murky when determining coverage for pharmaceuticals such as fertility drugs. (chicagobusiness.com)
  • Formally released by the Council for Affordable Health Coverage , the proposal calls for increasing competition, adopting a drug pricing model that rewards value over volume, empowering consumers to make informed choices, and rejecting flawed policies that undermine innovation and jeopardize patient safety. (biotech-now.org)
  • She said, "Insurance coverage offers less financial protection against out-of-pocket costs than it did in the past" (Rabin, New York Times , 1/23). (californiahealthline.org)
  • employers
  • Employers are feeling the cost pressures. (orlandosentinel.com)
  • The most popular cost-controlling methods for organizations are tiered pricing and a mail-order drug service, with 89% and 82% of employers currently implementing these initiatives. (ifebp.org)
  • Moving forward, employers will continue exploring new cost-saving measures like referenced-based pricing. (ifebp.org)
  • Finally, we were correct that employers would become more engaged in healthcare cost management with many adding "frozen carrots," or financial incentives to drive usage of services that lower healthcare costs. (fortune.com)
  • healthcare
  • For many years, CalPERS has been a bellwether of which direction healthcare costs are heading," said Larry Levitt, senior vice president at the nonprofit Kaiser Family Foundation. (latimes.com)
  • authorization
  • Sixty-five percent of the companies that responded to a recent survey by the Washington Business Group on Health said they would only cover such drugs if an employee's doctor obtained prior authorization from the health plan because it was considered medically necessary. (nytimes.com)
  • significantly
  • projected enrollment in the drug benefit has not changed significantly. (cms.gov)
  • The actual or "net" costs to the Federal government, accounting for Medicaid savings, are also significantly lower over 10 years, dropping from last year's estimated $737 billion to $678 billion. (cms.gov)
  • year
  • For the 10-year period from 2006-2015, the "total" Medicare drug benefit cost, without accounting for Medicaid savings, is now estimated to be about $130 billion less - $797 billion compared to an estimated $926 billion last year. (cms.gov)
  • The cost for filling all PPI, ACE inhibitor and ARB prescriptions in Ontario for one year, April 2008 to March 2009, was $2.48 million, $968,000 and $325,000 respectively. (redorbit.com)
  • It also said that it provided Gleevec or Tasigna free to 5,000 uninsured or underinsured Americans each year and to date had provided free drugs to more than 50,000 people in low-income countries. (nytimes.com)
  • She says the health system spent $140 million during its past fiscal year - July 2014 to June 2015 - on drugs, compared to $114 million in the previous year. (aha.org)
  • Rob Moroni, the company's assistant director of health plans, said GM expected a cost increase of about 20 percent this year, fueled by large numbers of older retirees covered by the company's plan. (orlandosentinel.com)
  • Yes, the U.S. pays 40 percent more for drugs than other countries do, and last year those costs rose 12.6 percent. (ctpost.com)
  • The company now plans on submitting a New Drug Application to the FDA for an accelerated approval for a second Duchenne drug, golodirsen, by the end of the year. (thestreet.com)
  • New drugs last year boosted spending for specialty pharmaceuticals 25% over the prior year, IMS Health Inc. reported in April. (businessinsurance.com)
  • The controversy centers on so-called specialty drugs, a somewhat imprecise term that generally encompasses products that can cost tens or even hundreds of thousands of dollars a year. (nytimes.com)
  • But drug costs are increasing much faster: Up 12.7% last year, they're expected to rise 16.6% this year. (chicagobusiness.com)
  • clinical
  • At Memorial, she oversees a team of pharmacists who pore over clinical studies to penetrate drug-company hype. (latimes.com)
  • To investigate the attitudes of senior anaesthetists toward issues of anaesthesia drug cost control, utilization, and education, and to determine patterns of drug use of common clinical scenarios. (springer.com)
  • Prescription drugs used to treat men's hair loss and enlarged prostate could have unintended side effects that were never reported in clinical trials. (emaxhealth.com)
  • Known as the Food and Drug Administration Reauthorization Act, the legislation will help streamline the clinical trial process, enhance drug safety, enhance competition for generics and biosimilar therapies, better incorporate patient perspectives into regulatory decisions, and more. (biotech-now.org)
  • Gleevec
  • Since then, the price has tripled, it said, even as Gleevec has faced competition from five newer drugs. (nytimes.com)
  • For one widely used cancer drug, Gleevec, the patient could pay more than $2,000 for a month's supply, says the Leukemia & Lymphoma Society. (patheos.com)
  • PBMs
  • At Senate Finance Committee hearings in March, the General Accounting Office questioned whether PBMs would be able to control costs under government disclosure requirements. (orlandosentinel.com)
  • PBMs say they can slow the pace for plans willing to limit members' drug choices. (orlandosentinel.com)
  • The best PBMs have expert panels that survey drugs within each class of treatment and pick a preferred brand. (chicagobusiness.com)
  • While employees usually aren't aware of it, many PBMs have begun to grant cash incentives to pharmacists who switch prescriptions to lower-cost alternatives, says Kristen Stagaman, a consultant with William M. Mercer Inc. in Chicago. (chicagobusiness.com)
  • plans
  • Nearly three in four Americans are in drug plans, but by the industry's count, drug spending is growing three times as fast as overall health spending, which rose about 6 percent in 1999. (orlandosentinel.com)
  • But many health plans -- hoping to induce consumers to switch to over-the-counter Claritin -- are increasing the co-payments members pay for these drugs, or requiring a special request for the other drugs from a patient's doctor. (nytimes.com)
  • percent
  • Our report shows that the cost of the program will be about 20 percent less in 2006," HHS Secretary Mike Leavitt said. (cms.gov)
  • Researchers say that new safety concerns have been identified for 33 percent of FDA approved drugs. (emaxhealth.com)
  • patient
  • A new UC Berkeley study has surprising findings about reference pricing and patient drug selection. (modernmedicine.com)
  • In March, Klein persuaded the hospital to substitute drugs that use a different kind of inhaler, one that could be loaded with the exact number of doses each patient needed. (latimes.com)
  • The Affordable Care Act created the Patient- Centered Outcomes Research Institute to address similar questions, but it is prohibited from considering the relative value of drugs. (ctpost.com)
  • The biopharmaceutical company, which won controversial FDA approval for a Duchenne Muscular Dystrophy drug, now confronts patient groups asking HHS to take its patents and drop the price of that drug. (thestreet.com)
  • But the FDA had a change of heart five months later when, over the objections of its own staff, the agency green-lighted the drug for use by a limited patient population and it called for more testing. (thestreet.com)
  • How much is given depends on body weight, so the cost varies from patient to patient. (sun-sentinel.com)
  • companies
  • Klein is careful to keep herself from coming under the influence of drug companies. (latimes.com)
  • is profiteering by drug companies and how elected officials in the various states respond to this. (patheos.com)
  • If the drug companies can buy the FDA and the United States Congress, do you seriously think they can't also buy the various state legislatures? (patheos.com)
  • The drug industry is criticizing the proposal, saying it will mainly benefit insurance companies that act as middlemen providing the benefit. (ktar.com)
  • The vast majority of companies in recent years have joined prescription benefit management (PBM) firms that have negotiated deep discounts with select drug manufacturers. (chicagobusiness.com)
  • Other companies are deciding not to cover "lifestyle drugs," such as the anti-impotence drug Viagra and the baldness medication Rogaine. (chicagobusiness.com)
  • cheaper
  • Most respondents (69.8-96.8%) felt they knew the cost of commonly used agents, many made considerable use of cheaper agents such as halothane, curare and morphine, and 61% re-used syringes containing residual drug. (springer.com)
  • nearly
  • The president touted his own role in the Pentagon's negotiations with Lockheed Martin for 90 F-35 fighter jets at a cost of nearly $9 billion, the lowest in the program's history. (foxnews.com)